高级搜索
立即登录 | 免费注册
当前位置 >   首页 > 医药资讯 >  药品动态  > 药品资讯内容

FDA声明魔力咖啡“膳食补充剂”中含有万艾可样化学成分

FDA states Magic Power Coffee 'dietary supplement' contains Viagra-like chemical

2010-06-24 【发表评论】
中文 | ENGLISH | 打印| 推荐给好友


 

ST LOUIS (MD Consult) - On June 19, 2010, the US Food and Drug Administration (FDA) issued a notice warning consumers to avoid using a product known as Magic Power Coffee. The product is an instant coffee and is marketed as a dietary supplement for the promotion of sexual enhancement.

An FDA analysis of Magic Power Coffee revealed the presence of hydroxythiohomosildenafil, a chemical similar to sildenafil and the active ingredient in Viagra. The agency states that this component of the product is considered an undeclared drug ingredient. The label describes the product as an "all natural dietary supplement."

When taken by persons who also take nitrate medications, hydroxythiohomosildenafil, like sildenafil, may lead to dangerous drops in blood pressure. Sexual enhancement products that claim to work as well as prescription products are likely to expose consumers to unpredictable risks and the potential for injury or even death, according to the FDA.

Magic Power Coffee is distributed on Internet sites and online auctions by multiple independent distributors participating in an online multilevel marketing scheme. It is sold in a 2-serving box and a 12-serving carton containing six 2-serving boxes.

The FDA is advising consumers who have experienced any negative adverse effects from sexual enhancement products to consult a health care professional and to safely discard the product. Adverse events may be reported to the FDA's MedWatch program.

圣路易斯(MD Consult)——2010619日,美国食品药品管理局(FDA)发布了一则通知,警告消费者切勿摄入名为魔力咖啡的饮品。该产品是一种速溶咖啡,以增强性功能的膳食补充剂形式销售。

FDA对魔力咖啡所做的一项分析显示,该产品中存在羟基硫基好猫西地那非(hydroxythiohomosildenafil),这种化学物质类似于西地那非,即伟哥中的有效成分。FDA声明,这种成分被视为未申报的药品成分。产品说明书将该产品描述为纯天然的膳食补充剂

服用硝酸盐类药物的患者同时服用羟基硫基好猫西地那非,类似于服用西地那非,也可能会导致血压危险性下降。据FDA称,声称与处方药同等有效的增强性功能产品可能会使消费者有不可预知的风险,还可能会招致损伤甚至是死亡。

魔力咖啡由加入网上多层次销售网络的多个独立分销商通过网站或网上拍卖分销。其市售形式为2袋装的小盒及12袋装的大盒(内含62袋装小盒)

对于因摄入增强性功能产品而发生任何不良反应的消费者,FDA建议其咨询医护专业人员并安全地处置产品,同时亦可将不良事件上报至FDAMedWatch系统


Subjects:
general_primary
学科代码:
内科学

请登录后发表评论, 点击此处登录。

疾病资源中心  疾病资源中心
 病例分析

 王燕燕 王曙

上海交通大学附属瑞金医院内分泌科

患者,女,69岁。2009年1月无明显诱因下出现乏力,当时程度较轻,未予以重视。2009年3月患者乏力症状加重,尿色逐渐加深,大便习惯改变,颜色变淡。4月18日入我院感染科治疗,诉轻度头晕、心慌,体重减轻10kg。无肝区疼痛,无发热,无腹痛、腹泻、腹胀、里急后重,无恶性、呕吐等。入院半月前于外院就诊,查肝功能:ALT 601IU/L,AST 785IU/L,TBIL 97.7umol/L,白蛋白 41g/L,甲状腺功能:游离T3 30.6pmol/L,游离T4 51.9pmol/L,心电图示快速房颤。
 

医学数据库  医学数据库



友情链接:中文版柳叶刀 | MD CONSULT | Journals CONSULT | Procedures CONSULT | eClips CONSULT | Imaging CONSULT | 论文吧 | 世界医学书库 医心网 | 前沿医学资讯网

公司简介 | 用户协议 | 条件与条款 | 隐私权政策 | 网站地图 | 联系我们

 互联网药品信息服务资格证书 | 卫生局审核意见通知书 | 药监局行政许可决定书 
电信与信息服务业务经营许可证 | 京ICP证070259号 | 京ICP备09068478号

Copyright © 2009 Elsevier.  All Rights Reserved.  爱思唯尔版权所有